Advaxis

$0.2879
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0026 (-0.90%) Today
+$0.0026 (+0.91%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell Advaxis and other stocks, options, and ETFs commission-free!

About ADXS

Advaxis, Inc. Common Stock, also called Advaxis, is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. The listed name for ADXS is Advaxis, Inc. Common Stock.

CEO
Kenneth A. Berlin
Employees
35
Headquarters
Princeton, New Jersey
Founded
1987
Market Cap
18.89M
Price-Earnings Ratio
Dividend Yield
Average Volume
7.80M
High Today
$0.308
Low Today
$0.2723
Open Price
$0.2966
Volume
8.57M
52 Week High
$1.48
52 Week Low
$0.2639

Collections

ADXS News

BenzingaNov 24

Why These 3 Pharma Stocks Are Moving Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has received FDA approval for the t
BenzingaNov 24

Stocks That Hit 52-Week Lows On Tuesday

Before 10 a.m. ET Tuesday, 3 stocks hit new 52-week lows. Noteables: Tempur Sealy Intl (NYSE: TPX) was the largest firm on a market cap basis to set a new 52-

ADXS Earnings

-$1.32
-$0.88
-$0.44
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Dec 17, Pre-Market

You May Also Like